Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT)

ClearPoint Demonstration Video

Issue 17 - The Cancer Letter

ETFs Holding CLPT, ClearPoint Neuro Inc

Zero DBS Electrode Infections Reported When Utilizing the ClearPoint® NeuroNavigation System - Legacy MEDSearch

ETFs Holding CLPT, ClearPoint Neuro Inc

NDA for Diazepam Buccal Film Accepted by FDA for Seizure Cluster Treatment

ClearPoint Neuro (CLPT) Stock: Path To Neurological Navigation Platform

Press Releases :: ClearPoint Neuro, Inc. (CLPT)

ClearPoint Navigation System for Drug Delivery

ClearPoint neuro (CLPT) - #162 av aborum - Biotek - TekInvestor - Norges Beste Aksjeforum

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

Stephanie Newton Korszen on LinkedIn: ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version…

ClearPoint Neuro, Inc. on LinkedIn: We are delighted to announce FDA Clearance and First-in-Human cases…